PUBLIC COMPANY
save$NVAXNOVAVAX INC
$NVAX8.0600-5.45%Gaithersburg, MD, USupdated 13h ago
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria.
community read0 votes
pipeline
4
marketed
1
phase 3
3
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(4)
pipeline depth4 products
3Phase 31Marketed
Marketed
Coronavirus Disease 2019 (COVID-19) vaccine 1
Coronavirus Disease 2019 (COVID-19)
Phase 3(Coronavirus disease 2019 (COVID-19) + influenza (trivalent)) vaccine
Coronavirus Disease 2019 (COVID-19)
Phase 3COVID/Influenza Combination Vaccine
Seasonal Influenza
Phase 3influenza (trivalent) vaccine
Seasonal Influenza
Upcoming
no upcoming catalysts on record
Recent(90d)
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 12m ago
Found something off?
comments(0)
5-min edit window · permanent after that